OVARIAN CANCER and US

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, August 28, 2009

Wednesday, August 26, 2009

Cancer specialists answer your questions - CNN.com (ovarian)



Cancer specialists answer your questions - CNN.com

OvPlex (UK) New blood test to detect ovarian cancer could save thousands



New blood test to detect ovarian cancer could save thousands

By Daily Mail Reporter
Last updated at 8:55 AM on 25th August 2009

A blood test that could save thousands of women's lives by detecting ovarian cancer at an early stage is to be launched in Britain.

The test, called OvPlex, is expected to be available for doctors to use by the end of the year.

It works by analysing just a few drops of blood to look for signs of five different chemicals released by tumour cells as they grow.

Tests show that when all five are detectable in the blood, there is a very good chance cancerous cells are forming on the ovaries.

Outside Australia, where the test was developed, Britain and Ireland are the first countries where it will be used to spot signs of cancer at a much earlier stage than doctors can do now.

More than 6,000 women a year in the UK are diagnosed with cancer of the ovaries and the annual death toll is around 4,500.

The disease accounts for about 5 per cent of cancer deaths in women. It is sometimes known as a 'silent killer' because, for many victims, symptoms only appear once it is already fairly advanced.

The tumours tend to grow slowly and research shows it can take an average of five years before a woman notices any symptoms and seeks medical help.

But the OvPlex test could catch cancers while they are still very small and have not spread.

If the disease is picked up early, 80 per cent of sufferers will still be alive after five years.

The main risk factors include a family history of the disease, having already had breast cancer and starting periods at a young age.

'Given the advantages of early detection of ovarian cancer, OvPlex may save many thousands of lives,' said Nick Gatsios, of HealthLinx, the Melbourne-based firm that developed it.

Dr Sarah Blagden, from the Ovarian Cancer Action Research Centre at Imperial College, London, said the OvPlex test looks 'very promising'.

Developing world gets tiny share of cancer money - Lance Armstrong



PLoS Medicine: The Dawning Era of Personalized Medicine Exposes a Gap in Medical Education



PLoS Medicine: The Dawning Era of Personalized Medicine Exposes a Gap in Medical Education

PLoS Medicine: Making the “Right” Health Care Decisions: Why Values Matter



PLoS Medicine: Making the “Right” Health Care Decisions: Why Values Matter

mTOR is a Promising Therapeutic Target Both in Cisplatin Sensitive and Cisplatin Resistant Clear Cell Carcinoma of the Ovary



NEJM -- Disclosure of Financial Relationships to Participants in Clinical Research



Hereditary ovarian cancer: biology, response to chemotherapy and prognosis



Effect of bilateral oophorectomy on women's long-term health



Women's awareness of ovarian cancer risks and symptoms: analysis of responses to an online survey shows that women ages 40 and older are not well info



Taking Action to Ease Suffering: Advancing Cancer Pain Control as a Health Care Priority -- Brawley et al., 10.3322/caac.20030 -- CA: A Cancer Journal for Clinicians



Taking Action to Ease Suffering: Advancing Cancer Pain Control as a Health Care Priority -- Brawley et al., 10.3322/caac.20030 -- CA: A Cancer Journal for Clinicians

Tuesday, August 25, 2009

2009 Risk of ovarian cancer in women with symptoms in primarycare: population based case-control study



Commentary: Diagnosing ovarian cancer--more problems than answers -- Fox 339: b3233 -- BMJ



Commentary: Diagnosing ovarian cancer--more problems than answers -- Fox 339: b3233 -- BMJ

Ovarian cancer: lymph node metastases (aortic/pelvic)



BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor....



Research Trove - Patients’ Online Data - NYTimes.com



Research Trove - Patients’ Online Data - NYTimes.com

Beyond Parity: Association of Ovarian Cancer With Length of Gestation and Offspring Characteristics.



Use of Hormone Replacement Therapy and the Risk of Colorectal Cancer -- Rennert et al., 10.1200/JCO.2009.22.0764 -- Journal of Clinical Oncology



Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in thecolorectal cancer familial registry in Ontario



full free text: Penetrance of colorectal cancer among MLH2/MSH2 carriers participating in the colorectal cancer familial registry in Ontario



Editorial: Maintenance Therapy for Ovarian Cancer: Of Helsinki and Hippocrates



Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1 -- Pecorelli et al., 10.1200/JCO.2009.21.9691 -- Journal of Clinical Oncology



Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1 -- Pecorelli et al., 10.1200/JCO.2009.21.9691 -- Journal of Clinical Oncology

Extreme cancer prevention surgery not a quick decision for women - The Globe and Mail



Extreme cancer prevention surgery not a quick decision for women - The Globe and Mail

A Population-Based Analysis of 1037 Malignant Ovarian Tumors in the Pediatric Population



A Population-Based Analysis of 1037 Malignant Ovarian Tumors in the Pediatric Population

Obstetrical & Gynecological Survey - Abstract: Volume 64(9) September 2009 p 593-595 Results from Four Rounds of Ovarian Cancer Screening in a Randomized Trial.



Obstetrical & Gynecological Survey - Abstract: Volume 64(9) September 2009 p 593-595 Results from Four Rounds of Ovarian Cancer Screening in a Randomized Trial.

Thursday, August 20, 2009

N.E.D. | Facebook



The debut EP from N.E.D.
CD will be released to the public on 9/8/09 in both online downloadable and hard copy formats. Also, band members will be selling CDs as well.

Host:N.E.D.
Time:1:00AM Tuesday, September 8th
Location:U.S.A.

Wednesday, August 05, 2009

Google Scholar Versus PubMed in Locating Primary Literature to Answer Drug-Related Questions: Abstract and Introduction



Google Scholar Versus PubMed in Locating Primary Literature to Answer Drug-Related Questions: Abstract and Introduction

Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model -- Lynch et al., 10.1503/cmaj.071574 -- Canadian Medical Association Journal



Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model -- Lynch et al., 10.1503/cmaj.071574 -- Canadian Medical Association Journal

Cases - Losing a Comforting Ritual - Treatment - NYTimes.com



For those who have never been seriously ill, treatment often seems cut and dried. You get sick, you get treated and, in theory, you get better. One day you’re a patient, the next you’re not. Simple, right?...

After Cancer, a Post-Treatment Letdown - Well Blog - NYTimes.com



After Cancer, a Post-Treatment Letdown - Well Blog - NYTimes.com

Personal Health - ‘Chemo Brain,’ the Fog After Chemotherapy, Gets More Attention - NYTimes.com



Tuesday, August 04, 2009

Carcinoma of unknown primary: Searching for the origin of metastases - JAAPA: Official Journal of the American Academy of Physician Assistants



Carcinoma of unknown primary: Searching for the origin of metastases - JAAPA: Official Journal of the American Academy of Physician Assistants

New Gene for Ovarian Cancer - BNC2 "EYES ON DNA"




New Gene for Ovarian Cancer - BNC2: "In September 2007, I interviewed two women who’d experienced ovarian cancer – Sandi Pniauskas and Carolyn Benivegna. Sadly, Carolyn died a year later but Sandi carries on her work to bring awareness to ovarian cancer. She is urging people to sign the petition for an ovarian cancer awareness postage stamp in memory of Carolyn."

Eye on DNA Exclusive Interview with Cancer Survivors Sandi Pniauskas and Carolyn Benivegna



Eye on DNA Exclusive Interview with Cancer Survivors Sandi Pniauskas and Carolyn Benivegna

Detecting Ovarian Cancer Early: Closing In on the Holy Grail - WSJ.com



As a result, even though ovarian cancer is relatively rare—the lifetime risk is 1 in 70, compared with 1 in 8 for breast cancer—it is frequently fatal.

Monday, August 03, 2009

Print the Petition (as below)



You can cut and paste this into a word program or contact Ovacome for a better copy:

USPS Petition
Ovarian Cancer Awareness Postage Stamp

We, the undersigned, fully support the proposal initiated in 2001, and requested every year since then, by Carolyn Benivegna. This proposal requests the creation of an Ovarian Cancer Awareness Postage Stamp. The heightened awareness can help save women’s lives, and we urge you to do this as quickly as possible. We collect signatures every year. Please sign year after year for us to send to the USPS Stamp committee each year.

# Name (please print) Signature City State
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

Return signatures to and if you have questions/comments:
Ovacome - Kim Snyder 2965 164th Avenue North, Clearwater, FL 33760 Email: OvCaSurvivor@verizon.net
Online petition: http://www.ipetitions.com/petition/ovcastamp/

Sign petition for ovarian cancer please



Hello,
I am with Ovacome in Tampa, FL. I am collecting the signatures for a Ovarian Cancer USPS postage stamp project.

I have attached a signature form and the email. I would like to ask you a huge favor and see if you can have people sign the petition form.

The bottom of the page has my address. Once you have collected any signatures, please send me the signed forms.

I am collecting them to send to the USPS Stamp committee. ( Ovacome - Kim Snyder 2965 164th Avenue North, Clearwater, FL 33760 Email: OvCaSurvivor@verizon.net

Online petition: http://www.ipetitions.com/petition/ovcastamp/ ).

If you or anyone has any questions, please contact me.

Thanks,

Kim Snyder

Email: OvCaSurvivor@verizon.net

Please forward this to your friends and family.

Together we can make an OvCa stamp a reality. We have been requesting an ovarian cancer awareness postage stamp annually since 2001 and need your help. If you would like to support our goals, please sign our online petition. We will submit a request to the U.S. Postal Service along with the signatures that share in our quest to make this a reality.

In memory of Carolyn Benivegna, survivors, family and friends of those touched by ovarian cancer, please click on the link and help us send our message through the U. S. Postal Service. http://www.ipetitions.com/petition/ovcastamp

Thank you.
Kim

Ovacome
www.ovacome.org
ovcasurvivor@verizon.net

http://www.ipetitions.com/petition/ovcastamp

on behalf of the late Carolyn Benivegna: Ovarian Cancer Awareness Postage Stamp Petition : [ powered by iPetitions.com ]



Please circulate and sign this petition on behalf of not only Carolyn but ovarian cancer women and their families/friends.